Advertisement
Advertisement
CTMX
CytomX Therapeutics, Inc.
2.70
USDSponsored
-0.05
-1.82%
Sep 25, 15:59 UTC -4
Closed
After-Market
2.70
0.00
0.00%
CytomX Therapeutics, Inc. Financial Snapshot
| Market Cap | 588.33M |
| Beta | 2.14 |
| Earnings Per Share (EPS) | -0.50 |
| Price-to-Book (P/B) Ratio | 1.66 |
| Operating Margin | -435.21% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -38.46% |
| Current Ratio | 9.36% |
| Free Cash Flow | -43.62M |
